Gladstone Institutional Advisory LLC Regeneron Pharmaceuticals, Inc. Transaction History

Gladstone Institutional Advisory LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $2,769 - $3,377	-4 Reduced 0.46%	873 $718,000
Q2 2023 Aug 10, 2023	BUY	$700.03 - $830.35 $613,926 - $728,216	877 New	877 $630,000
Q2 2022 Jan 27, 2023	SELL	$548.35 - $738.84 $269,239 - $362,770	-491 Reduced 33.38%	980 $579,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $537,383 - $724,063	980 New	980 $579,000
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $799,459 - $986,996	-1,471 Closed	0 $0
Q3 2021 Jan 27, 2023	BUY	$574.03 - $680.96 $540,162 - $640,783	941 Added 177.55%	1,471 $890,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $844,398 - $1 Million	1,471 New	1,471 $890,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $253,499 - $322,229	-530 Closed	0 $0
Q3 2020 Jan 27, 2023	BUY	$544.75 - $658.21 $288,717 - $348,851	530 New	530 $297,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $113,308 - $136,907	-208 Reduced 28.18%	530 $297,000
Q2 2020 Aug 17, 2020	BUY	$493.32 - $643.92 $364,070 - $475,212	738 New	738 $460,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.